Universitätsklinikum Heidelberg Innere Medizin V
Germany
Vortrag
The impact of allogeneic hematopoietic cell transplantation (alloHCT) on the natural course of poor-risk non-Hodgkin lymphoma (NHL): A retrospective intent-to-transplant (ITT) analysis.
Speaker